lung cancer

J&J looks to expand Rybrevant lung cancer indication to larger EGFR-positive population
Endpoints
Tue, 07/26/22 - 11:03 am
JNJ
Rybrevant
lung cancer
non-small cell lung cancer
Roche keeps the faith in new cancer immunotherapy despite trial setbacks
BioPharma Dive
Tue, 06/7/22 - 10:30 am
Roche
tiragolumab
lung cancer
clinical trials
ASCO 2022
ASCO: It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says
Fierce Biotech
Mon, 06/6/22 - 10:33 am
ASCO 2022
Mirati Therapeutics
Amgen
Lumakras
adagrasib
lung cancer
ASCO: Bristol Myers adds to debate with Opdivo's presurgery lung cancer performance
Fierce Pharma
Mon, 06/6/22 - 09:59 am
ASCO 2022
Bristol Myers Squibb
lung cancer
Opdivo
After deeming success unlikely, Merck KGaA cuts lung cancer trial to consider future of ATR inhibitor
Fierce Biotech
Sun, 06/5/22 - 11:35 pm
Merck KGaA
EMD Serono
clinical trials
oncology
lung cancer
berzosertib
non-small cell lung cancer
ASCO: Merck touts Keytruda's 'convergent' benefits across postsurgery lung cancer patient groups
Fierce Pharma
Mon, 05/30/22 - 10:18 am
ASCO 2022
Merck
Keytruda
lung cancer
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
Motley Fool
Sat, 04/23/22 - 03:54 pm
Novavax
vaccines
COVID-19
Axsome Therapeutics
FDA
Novocure
lung cancer
Personalized Blood Test Detecting ctDNA Can Help Predict Lung Cancer Relapse
Xtalks
Wed, 04/6/22 - 12:06 pm
Medtech
diagnostics
lung cancer
ctDNA
RaDaR
BioNTech and Regeneron expand their cancer partnership, pushing new Libtayo combo into NSCLC
Endpoints
Tue, 03/8/22 - 10:41 am
BioNTech
Regeneron
lung cancer
vaccines
MRNA
Libtayo
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono
Fierce Pharma
Tue, 03/1/22 - 10:32 am
AstraZeneca
Ono Pharmaceutical
lung cancer
patents
Imfinzi
American Lung Association campaign, backed by pharma, tackles lack of diversity in lung cancer trials
Fierce Pharma
Fri, 02/11/22 - 10:31 am
pharma marketing
lung cancer
American Lung Association
FDA sends signal with tough questions of Lilly at cancer drug meeting
BioPharma Dive
Thu, 02/10/22 - 10:37 pm
Eli Lilly
Innovent Biologics
lung cancer
clinical trials
China
Amgen hold-up gives Mirati a vital lifeline
EP Vantage
Thu, 02/10/22 - 10:12 am
Amgen
Mirati Therapeutics
Lumakras
lung cancer
clinical trials
FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag
Pharmaforum
Thu, 12/23/21 - 11:53 am
Daiichi Sankyo
FDA
antibody-drug conjugate
lung cancer
HER3
patritumab deruxtecan
Startup Mythic Therapeutics emerges with $103M to control fate of ADC cancer drugs
MedCity News
Thu, 12/16/21 - 12:02 pm
Mythic Therapeutics
antibody-drug conjugate
startups
cancer
lung cancer
oncology
Roche builds case for TIGIT combo in untreated lung cancer
Pharmaforum
Fri, 12/10/21 - 10:50 am
Roche
anti-TIGIT
tiragolumab
Tecentriq
lung cancer
Bristol Myers adds to neoadjuvant win for Opdivo in lung cancer, escalating early cancer showdown with Merck
Endpoints
Mon, 11/8/21 - 10:58 am
Bristol Myers Squibb
Merck
Opdivo
lung cancer
Keytruda
Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come
Fierce Pharma
Mon, 11/8/21 - 10:54 am
Takeda
Alunbrig
value-based pricing
drug pricing
lung cancer
Novartis hits another setback in plan to repurpose rare disease drug in lung cancer
BioPharma Dive
Mon, 10/25/21 - 11:51 pm
Novartis
clinical trials
canakinumab
Ilaris
lung cancer
Calithera buys itself a plan B
EP Vantage
Tue, 10/19/21 - 10:43 am
Calithera Biosciences
Takeda
telaglenastat
sapanisertib
mivovatinib
lung cancer
B cell lymphoma

Pages